Inventor · disambiguated record
Richard Jove
Also filed as: JOVE RICHARD
30 granted patents·12 pending applications·133 citations·filing 2001–2022
96Inventor score
Top patents by PatentIndex Score
42 records- 0194US9828342B2Isatin derivatives, pharmaceutical compositions thereof, and methods of use thereofHOPE CITY·Filed 2013·Granted Nov 28, 2017·19 cites·8 claims
- 0291US7638122B2Stat3 antagonists and their use as vaccines against cancerUNIV SOUTH FLORIDA·Filed 2003·Granted Dec 29, 2009·41 cites·12 claims
- 0388US9688982B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2013·Granted Jun 27, 2017·7 cites·4 claims
- 0487US11208654B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2019·Granted Dec 28, 2021·1 cites·16 claims
- 0587US8748405B2Methods and compositions for the treatment of cancer or other diseasesYU HUA·Filed 2011·Granted Jun 10, 2014·7 cites·3 claims
- 0687US7763585B2Methods for inhibiting tumor cell proliferationUNIV SOUTH FLORIDA·Filed 2007·Granted Jul 27, 2010·7 cites·10 claims
- 0787US7238372B2Methods for inhibiting tumor cell proliferationUNIV SOUTH FLORIDA·Filed 2004·Granted Jul 3, 2007·20 cites·4 claims
- 0886US10253318B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2017·Granted Apr 9, 2019·3 cites·14 claims
- 0984US9856273B2ETP derivativesHOPE CITY·Filed 2016·Granted Jan 2, 2018·2 cites·19 claims
- 1084US9527868B2ETP derivativesHOPE CITY·Filed 2015·Granted Dec 27, 2016·3 cites·15 claims
- 1184US9200280B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2014·Granted Dec 1, 2015·4 cites·3 claims
- 1283US8691799B2Materials and methods for treatment of cancer and identification of anti-cancer compoundsSEBTI SAID M·Filed 2011·Granted Apr 8, 2014·2 cites·19 claims
- 1382US10435367B2Indirubin derivatives, and uses thereofHOPE CITY·Filed 2013·Granted Oct 8, 2019·3 cites·13 claims
- 1480US7951374B2Methods for inhibiting STAT3 signaling in immune cellsUNIV SOUTH FLORIDA·Filed 2005·Granted May 31, 2011·1 cites·14 claims
- 1579US2023193258A1Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2021·Application pending·0 cites
- 1676US9512076B2Indirubin derivatives and uses thereof in treating chronic myelogenous leukemiaHOPE CITY·Filed 2013·Granted Dec 6, 2016·2 cites·3 claims
- 1776US8609639B2Stat3 inhibitor having anti-cancer activity and methodsTURKSON JAMES·Filed 2007·Granted Dec 17, 2013·2 cites·21 claims
- 1874US10246471B2ETP derivativesHOPE CITY·Filed 2017·Granted Apr 2, 2019·1 cites·21 claims
- 1974US9200279B2Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2014·Granted Dec 1, 2015·1 cites·4 claims
- 2073US8722698B2Berbamine derivativesHORNE DAVID·Filed 2010·Granted May 13, 2014·2 cites·9 claims
- 2169US7342095B2Peptidomimetic inhibitors of STAT activity and uses thereofUNIV SOUTH FLORIDA·Filed 2004·Granted Mar 11, 2008·3 cites·17 claims
- 2268US7842671B1Peptidomimetic inhibitors of STAT activity and uses thereofUNIV SOUTH FLORIDA·Filed 2007·Granted Nov 30, 2010·0 cites·17 claims
- 2367US7615638B2Synthesis of grossularines-1 and analogs thereof and method of useHOPE CITY·Filed 2007·Granted Nov 10, 2009·1 cites·16 claims
- 2465US11524937B2Indirubin derivatives, and uses thereofHOPE CITY·Filed 2019·Granted Dec 13, 2022·0 cites·14 claims
- 2565US2009227489A1STAT3 Agonists and Antagonists and Therapeutic Uses ThereofUNIV JOHNS HOPKINS·Filed 2009·Application pending·0 cites
- 2661US7807662B2Platinum IV complex inhibitorUNIV SOUTH FLORIDA·Filed 2005·Granted Oct 5, 2010·0 cites·7 claims
- 2761US2010297061A1Stat3 antagonists and their uses as vaccines against cancerUNIV SOUTH FLORIDA·Filed 2009·Application pending·0 cites
- 2860US9233976B2Berbamine derivativesHOPE CITY·Filed 2014·Granted Jan 12, 2016·0 cites·5 claims
- 2959US2023174483A1Indirubin derivatives, and uses thereofHOPE CITY·Filed 2022·Application pending·0 cites
- 3059US2008214436A1Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2007·Application pending·0 cites
- 3158US2007072822A1STAT3 agonists and antagonists and therapeutic uses thereofJOHNS HOPKINS UNIVERSITY A MAR·Filed 2006·Application pending·0 cites
- 3257US2014296128A1Materials and methods for treatment of cancer and identification of anti-cancer compoundsSEBTI SAID M·Filed 2014·Application pending·0 cites
- 3355US8598230B2Methods for inhibiting tumor cell proliferationTURKSON JAMES·Filed 2010·Granted Dec 3, 2013·0 cites·23 claims
- 3455US2004052762A1Stat3 agonists and antagonists and therapeutic uses thereofFiled 2001·Application pending·0 cites
- 3553US8153596B2Use of SH2 STAT3/STAT1 peptidomimetics as anticancer drugsSEBTI SAID M·Filed 2009·Granted Apr 10, 2012·0 cites·8 claims
- 3652US9345682B2Inhibition of STAT3 signal transduction for human cancer therapyJOVE RICHARD·Filed 2006·Granted May 24, 2016·0 cites·6 claims
- 3752US2010247427A1Methods of inhibiting cell growth and methods of enhancing radiation responsesUNIV SOUTH FLORIDA·Filed 2006·Application pending·0 cites
- 3851US8133692B2Methods of predicting responsiveness to chemotherapeutic agents and selecting treatmentsJOVE RICHARD·Filed 2006·Granted Mar 13, 2012·1 cites·22 claims
- 3949US7998947B2Materials and methods for treatment of cancer and identification of anti-cancer compoundsUNIV SOUTH FLORIDA·Filed 2002·Granted Aug 16, 2011·0 cites·18 claims
- 4043US2006030536A1Combination therapies for cancer and proliferative angiopathiesUNIV SOUTH FLORIDA·Filed 2005·Application pending·0 cites
- 4142US2007213288A1Adenoviral Vector Capable of Infecting Tumor Cells and Eliminating the Function of STAT3UNIV SOUTH FLORIDA·Filed 2006·Application pending·0 cites
- 4236US2011071210A1Methods and compositions for the treatment of cancer or other diseasesHOPE CITY·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard Jove files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →